randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 - Annals Neurology A randomized, double-blind, placebo-controlled, phase
A randomized, double blind, placebo controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertension Hypertension Research In the randomized, double blind, placebo controlled, global Phase III trial recently presented in the ASCO 2024 annual meeting, consolidation treatment with #durvalumab significantly improved clinical outcomes for patients with limited stage small cell Retrospective observational study on the use of acetyl l carnitine in ALS Journal of Neurology Springer Nature Link Acetyl L Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta Analysis of Randomized Controlled Trials PLOS One
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

